- Case report
- Open Access
Cardiovascular magnetic resonance in cardiac sarcoidosis with MR conditional pacemaker in situ
© Quarta et al; licensee BioMed Central Ltd. 2011
Received: 14 February 2011
Accepted: 3 May 2011
Published: 3 May 2011
Cardiovascular implantable electronic devices represent important limitations to magnetic resonance imaging (MRI). Recently, MRI-conditional dual chamber pacemakers and leads have become available. We describe a case of a patient with neuro-sarcoidosis presenting with diplopia and hydrocephalus requiring an MRI-conditional programmable ventriculo-peritoneal shunt, who developed complete heart block. In view of the ongoing need for neuro-imaging, MRI-conditional dual chamber pacemaker and leads were implanted. Cardiac and brain MRI were requested to guide immunosupression. Overall the scans demonstrated stable neurological disease, but confirmed cardiac sarcoid, with oedema on T2 weighted images suggesting active disease and extensive sub-endocardial late gadolinium enhancement, including the basal septum. This case illustrates why sarcoid patients who develop bradyarrhythmias should ideally have an MRI-conditional pacing system.
In the last decade, magnetic resonance imaging (MRI) has grown dramatically. At the same time, a growing number of patients receive cardiovascular implantable electronic devices (pacemaker, implantable-cardioverter defibrillators, bi-ventricular devices), a known contra-indication to MRI. It has been estimated that a patient with a cardiovascular electronic device has a 50-75% lifetime requirement for MRI, which would usually be denied . A position paper from the European Heart Rhythm Association and the Working Group on Cardiovascular Magnetic Resonance of the European Society of Cardiology  and a scientific statement from the American Heart Association  on MRI in individuals with cardiovascular implantable electronic devices have been published. Recently, an MRI-conditional dual chamber pacemaker has become available and represents an important step forward to overcome one of the major limitations of MRI.
Additional file 1: Top: SSFP gradient echo cine (left) and spoiled gradient echo (right) cine four chamber views. SSFP images are more susceptible to artefacts from pacemaker leads, but image quality is good. Bottom: SSFP-GRE short axis views, showing no regional wall motion abnormalities. (AVI 17 MB)
The advent of MRI-conditional devices overcomes an important limitation in disease management. Here, a multidisciplinary team approach and the use and management of two concurrent MR conditional devices  permitted ongoing, comprehensive assessment of multisystem sarcoidosis [4, 5]. Ironically, cardiovascular MRI detected occult cardiac disease that suggests the possible future requirement for an implantable-cardioverter defibrillator. As yet, such devices are not MRI conditional. Fortunately, she has no other high risk features  and her device has not detected any ventricular arrhythmia. Our case illustrates why sarcoid patients who develop bradyarrhythmias should ideally have an MRI-conditional pacing system.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Conflict of interests
The authors declare that they have no competing interests.
- Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P, Auricchio A, Priori S, Sommer T: Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace. 2008, 10: 336-46. 10.1093/europace/eun021.View ArticlePubMedGoogle Scholar
- Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, Martin ET, Smith JM, Wilke N, Shellock FS, American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Radiology and Intervention: Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2007, 116: 2878-91. 10.1161/CIRCULATIONAHA.107.187256.View ArticlePubMedGoogle Scholar
- Wilkoff BL, Bello D, Taborsky M, Vymazal J, Kanal E, Heuer H, Hecking K, Johnson WB, Young W, Ramza B, Akhtar N, Kuepper B, Hunold P, Luechinger R, Puererfellner H, Duru F, Gotte MJ, Sutton R, Sommer T, EnRhythm MRI SureScan Pacing System Study Investigators: Magnetic Resonance Imaging in Patients with a Pacemaker System Designed for the MR Environment. Heart Rhythm. 2011, 8: 65-73. 10.1016/j.hrthm.2010.10.002.View ArticlePubMedGoogle Scholar
- Iannuzzi MC, Rybicki BA, Teirstein AS: Sarcoidosis. N Engl J Med. 2007, 357: 2153-65. 10.1056/NEJMra071714.View ArticlePubMedGoogle Scholar
- Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ: Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009, 120: 1969-77. 10.1161/CIRCULATIONAHA.109.851352.PubMed CentralView ArticlePubMedGoogle Scholar
- Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons: ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008, 117: e350-408.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.